User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions

User:Jukeboksi/Wiki.study/Natural therapeutics (edit)

Revision as of 12:54, 16 July 2020

149 bytes removed , 16 July 2020

Undo revision 52958 by Jukeboksi (talk) no point in restricting to only chronological ordering, when contextual closeness is desired

Jukeboksi

Bureaucrats, developer, Administrators

9,854

edits

@@ Line 216: / Line 216: @@
 ''' Studies about brain tumors and cannabis '''
-* '''2018''' | [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a perspective article published in Frontiers in Integrative Neuroscience by [[w:Frontiers Media]]
+* [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article
-* '''2010''' | [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a comparative study, published in [[w:Neurochemistry International]]
+* [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 comparative study, published in [[w:Neurochemistry International]]
-* '''2009''' | [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''clinical trial''', published in [[w:Neuropharmacology (journal)]]
+* [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 '''clinical trial''', published in [[w:Neuropharmacology (journal)]]
-* '''2009''' | [http://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a study, published in [[w:Brain Research Bulletin]]
+* [http://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 study, published in [[w:Brain Research Bulletin]]
-* '''2007''' | [http://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''review''', published in [[w:Molecular Neurobiology (journal)]]
+* [http://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2007 '''review''', published in [[w:Molecular Neurobiology (journal)]]
-* '''2005''' | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089 'Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a study, published in [[w:British Journal of Pharmacology]]
+* [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089 'Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, 2005 study, published in [[w:British Journal of Pharmacology]]
-* '''2004'''| [http://www.ncbi.nlm.nih.gov/pubmed/15275820 'Hypothesis: cannabinoid therapy for the treatment of gliomas?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''review''', published in [[w:Neuropharmacology (journal)]]
+* [http://www.ncbi.nlm.nih.gov/pubmed/15275820 'Hypothesis: cannabinoid therapy for the treatment of gliomas?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 '''review''', published in [[w:Neuropharmacology (journal)]]
-* '''2004''' | [http://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]]
+* [http://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]]
-* '''2001''' | [http://www.ncbi.nlm.nih.gov/pubmed/11479216 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a study published in [[w:Cancer Research (journal)]]
+* [http://www.ncbi.nlm.nih.gov/pubmed/11479216 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2001 study published in [[w:Cancer Research (journal)]]